You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:


Last Updated: October 2, 2023

VECTICAL Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Vectical patents expire, and what generic alternatives are available?

Vectical is a drug marketed by Galderma Labs Lp and is included in one NDA.

The generic ingredient in VECTICAL is calcitriol. There are ten drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the calcitriol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vectical

A generic version of VECTICAL was approved as calcitriol by TEVA on October 12th, 2001.

  Try a Trial

Drug patent expirations by year for VECTICAL
Drug Prices for VECTICAL

See drug prices for VECTICAL

Recent Clinical Trials for VECTICAL

Identify potential brand extensions & 505(b)(2) entrants

University of California, San FranciscoPhase 4
Emer, Jason, M.D.Phase 4
Galderma LaboratoriesPhase 4

See all VECTICAL clinical trials

Pharmacology for VECTICAL
Drug ClassVitamin D3 Analog

US Patents and Regulatory Information for VECTICAL

VECTICAL is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting VECTICAL

Exclusivity Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp VECTICAL calcitriol OINTMENT;TOPICAL 022087-001 Jan 23, 2009 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.